Loading clinical trials...
Loading clinical trials...
This is an expanded access study with ANG1005 treatment for two individual patients from Protocol ANG1005-CLN-03 with WHO Grade III Anaplastic Astrocytoma and WHO Grade III Anaplastic Oligodendrogliom...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Angiochem Inc
NCT02800486 · Glioblastoma, Anaplastic Astrocytoma, and more
NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more
NCT05084430 · Glioblastoma Multiforme, Anaplastic Astrocytoma, and more
NCT05956821 · Glioblastoma Multiforme, Anaplastic Astrocytoma, and more
NCT04780009 · Glioblastoma Multiforme, Anaplastic Astrocytoma
UC Irvine Health
Orange, California
Univeristy of Texas Health Science Center in San Antonio
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions